Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.85)
# 3,040
Out of 4,843 analysts
169
Total ratings
44.29%
Success rate
-2.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $92.17 | +3.07% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $552.34 | +17.68% | 13 | Dec 2, 2024 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $7 → $5 | $3.70 | +35.14% | 15 | Nov 11, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $10.53 | +13.96% | 12 | Jul 15, 2024 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $135 → $130 | $140.50 | -7.47% | 15 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $127.12 | -25.27% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $82.98 | +18.10% | 9 | Nov 22, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $85.94 | -1.09% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $29.58 | -49.29% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $325.03 | +5.53% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $3.40 | +311.76% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $30.50 | +57.38% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $78.22 | +30.40% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $105.26 | -44.90% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $11.47 | +74.37% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $85.80 | +52.68% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $133.58 | -0.43% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $382.64 | -42.50% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $122.27 | +209.15% | 2 | Feb 25, 2022 |
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $92.17
Upside: +3.07%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $552.34
Upside: +17.68%
Sight Sciences
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.70
Upside: +35.14%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $10.53
Upside: +13.96%
iRhythm Technologies
Jul 15, 2024
Maintains: Overweight
Price Target: $135 → $130
Current: $140.50
Upside: -7.47%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $127.12
Upside: -25.27%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $82.98
Upside: +18.10%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $85.94
Upside: -1.09%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $29.58
Upside: -49.29%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $325.03
Upside: +5.53%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $3.40
Upside: +311.76%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $30.50
Upside: +57.38%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $78.22
Upside: +30.40%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $105.26
Upside: -44.90%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $11.47
Upside: +74.37%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $85.80
Upside: +52.68%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $133.58
Upside: -0.43%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $382.64
Upside: -42.50%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $122.27
Upside: +209.15%